Cytokinetics' chief executive, Robert Blum, said the new deal with Royalty Pharma “reinforces our shared conviction in the value of our cardiac myosin-focused pipeline of drug candidates.” ...

Cytokinetics should hear back from the FDA ... In the company's third-quarter results update, chief executive Robert Blum said that aficamten has a "next-in-class safety and efficacy profile ...

Robert Peston is ITV’s political editor, presenter of the politics show “Peston” and the podcast “The Rest is Money”, and founder of the education charity, Speakers for Schools (www ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

A biotech in­cu­bat­ed by RA Cap­i­tal has se­cured a $57.5 mil­lion Se­ries B to be­gin a mid-stage tri­al for its car­dio drug this quar­ter and … ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

At close: 11 April at 16:00:01 GMT-4 ...

At close: April 11 at 4:00:01 PM EDT ...